Somatostatin does not prevent serotonin release and flushing during chemoembolization of carcinoid liver metastases

Anesthesiology

Volumn 98, Issue 4, 2003, Pages 1007-1011

  Zimmer, Christian ^a   Kienbaum, Peter ^b   Wiesemes, Richard ^b   Peters, Jürgen ^b  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CLEMASTINE; DIPYRONE; KETANSERIN; OCTREOTIDE; PENTETREOTIDE IN 111; PHENYLEPHRINE; PIRITRAMIDE; PREDNISOLONE; REMIFENTANIL; SEROTONIN; SOMATOSTATIN;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CARCINOID SYNDROME; CASE REPORT; CLINICAL FEATURE; CONTINUOUS INFUSION; DIARRHEA; DISEASE COURSE; FEMALE; FLUSHING; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; HYPOTENSION; LIVER METASTASIS; PAIN; PRIORITY JOURNAL; SEROTONIN BLOOD LEVEL; SEROTONIN RELEASE; TREATMENT OUTCOME;

ANESTHESIA; CARCINOID TUMOR; CHEMOEMBOLIZATION, THERAPEUTIC; FEMALE; FLUSHING; HEMODYNAMIC PROCESSES; HORMONE ANTAGONISTS; HUMANS; LIVER NEOPLASMS; MALIGNANT CARCINOID SYNDROME; MIDDLE AGED; SEROTONIN; SOMATOSTATIN;

EID: 0037381751     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200304000-00030     Document Type: Article

References (18)

1. Modlin JM, Sandor A: An analysis of 8305 cases of carcinoid tumors. Cancer 1997; 79:813-29
2. Kulke HM, Mayer R: Carcinoid tumors. N Engl J Med 1999; 340:858-68
3. Thorson A, Biörck G, Björkmann G, Waldenström J: Malignant carcinoid of the small intestine with metastases to the liver, valvular disease of the right side of the heart (pulmonary stenosis and tricuspid regurgitation without septal defects), peripheral vasomotor symptoms, bronchoconstriction, and an unusual type of cyanosis: a clinical and pathological syndrome. Am Heart J 1954; 47:795-817
4. Drougs JG, Anthony LB, Blair TK, Lopez RR, Wright JK Jr, Chapman WC, Webb L, Mazer M, Meranze S, Pinson CW: Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg 1998; 175:408-12
5. Roizen MF: Anesthetic implications of concurrent diseases, Anesthesia, 5th edition. Edited by Miller RD. Philadelphia, Churchill Livingstone, 2000, pp 982-4
6. Veall GRQ, Peacock JE, Bax ND, Reilly CS: Review of the anaesthetic management of 21 patients undergoing laparotomy for carcinoid syndrome. Br J Anaesth 1994; 72:335-41
7. Kinney MAO, Warner ME, Nagorney MD, Rubin J, Schroeder DR, Maxson PM, Warner MA: Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours. Br J Anaesth 2001; 87:447-52
8. Holdcroft A: Hormones and the gut. Br J Anaesth 2000; 85:58-68
9. Nilsson O, Kölby L, Wängberg B, Wigander A, Billig H, William-Olsson L, Fjälling M, Forsell-Aronson E, Ahlman H: Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy, and response to octreotide treatment in patients with carcinoid tumours. Br J Cancer 1998; 77:632-7
10. Janson ET, Gobl A, Kälkner KM, Öberg K: A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridisation for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients. Cancer Res 1996; 56:2561-5
11. Janson ET, Stridsberg M, Gobl A, Westlin JE, Öberg K: Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunhistochemical investigation with somatostatin receptor subtype 2 antibodies. Cancer Res 1998; 58:2375-8
12. Racke K, Reimann A, Schwörer H, Kilbinger H: Regulation of 5-HT release from enterochromaffin cells. Behav Brain Res 1996; 73:83-7
13. Kim M, Javed NH, Yu JG, Christofi F, Cooke HJ: Mechanical stimulation activates Gαq signalling pathways and 5-hydroxytryptamine release from human carcinoid BON cells. J Clin Invest 2001; 108:1051-9
14. Conlon JM, Deacon CF, Richter G, Stöckmann F, Creutzfeld W: Circulating tachykinins (substance P, neurokinin A, neuropeptide K) and the carcinoid flush. Scand J Gastroenterol 1987; 22:97-105
15. Kema IP, de Vries EGE, Schellings AMJ, Postmus PE, Muskiet AJ: Improved diagnosis of carcinoid tumors by measurement of platelet serotonin. Clin Chem 1992; 38:534-40
16. Törnebrandt K, Nobin A, Ericsson M, Thomson D: Circulation, respiration and serotonin levels in carcinoid patients during neurolept anaesthesia. Anaesthesia 1983; 38:957-67
17. Ahlman H, Ahlund L, Dahlström A, Martner J, Stenquist O, Tylen U: SMS 201-995 and provocation tests in preparation of patients with carcinoids for surgery or hepatic arterial embolization. Anesth Analg 1988; 67:1142-8
18. Ockert DBM, White RD: Anesthetic management of patients with carcinoid heart disease undergoing cardiac surgery: two case reports and a review of previous experience. J Cardiothorac Anesth 1988; 2:658-65